Peixiang Lan

10PUBLICATIONS
46CO-AUTHORS
Genome structure and regulationPredictive and prognostic markersMolecular targetsMedical infection agents (incl. prions)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 18, 2026
In vivo CRISPR screens identify the glutamine transporter SLC1A5 as a metabolic barrier to antitumor immunity.

|Jun 08, 2026
PARK7-Mediated Delactylation of SF3B Reprograms RNA Splicing to Attenuate Fibrosis and Promote Antitumor Immunity.

|May 20, 2026
PARK7-induced delactylation of ATAD3A impairs mitochondrial fitness to promote exhaustion of tumor-infiltrating CD8+ T cells.

|Apr 27, 2026
CD1d functions as a ligand for PIRA2 to drive macrophage activation in nonalcoholic fatty liver disease.

|Jan 05, 2026
BHLHE40 Orchestrates Effector Tissue-Resident Memory CD8+ T Cells and Limits Long-Term Survival of Kidney Graft.

Junbo Li, Bo Yang, Tianhui Pan

|Jun 24, 2025
Setdb1 ablation in macrophages attenuates fibrosis in heart allografts.

Zhibo Ma, Xi Zhou, Wenlong Jia

Pageof 2

Frequent Collaborators

3 joint publications

Xiaosheng Tan

2 joint publications

Zhibo Ma

2 joint publications

Wenlong Jia

2 joint publications

Gang Chen